Do you start Angiotensin-Converting Enzyme (ACE) inhibitors for ascites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Anxiolytics are not typically started as a primary treatment for ascites, and the management of ascites primarily involves sodium restriction, fluid restriction in some cases, and diuretic therapy. The standard diuretic regimen begins with spironolactone (an aldosterone antagonist) at 100mg daily, often combined with furosemide (a loop diuretic) at 40mg daily, as recommended by the most recent guidelines 1. These doses can be gradually increased as needed, maintaining a ratio of 100mg spironolactone to 40mg furosemide, up to maximum doses of 400mg and 160mg respectively. The goal is to achieve a weight loss of 0.5-1kg/day in patients with peripheral edema, or 0.5kg/day in those without edema. For patients with refractory ascites, therapeutic paracentesis or transjugular intrahepatic portosystemic shunt (TIPS) may be considered. Anxiolytics might only be used if there's significant anxiety associated with the condition, but they're not part of the standard treatment protocol for ascites itself and should be used cautiously in patients with liver disease due to potential hepatic metabolism issues.

Some key points to consider in the management of ascites include:

  • Moderate sodium restriction (2 g or 90 mmol/day) and diuretics (spironolactone with or without furosemide) are the first-line treatment in patients with cirrhosis and grade 2 ascites 1.
  • After ascites is adequately mobilized, attempts should be made to taper the diuretics to the lowest dose necessary to maintain minimal or no ascites to prevent the development of adverse effects 1.
  • Fluid restriction is not necessary for ascites management unless there is concomitant moderate or severe hyponatremia (serum sodium ≤ 125 mmol/L) 1.
  • In patients receiving diuretics, body weight and serum creatinine and sodium should be regularly monitored to assess response and to detect the development of adverse effects 1.

It's also important to note that the management of ascites should be individualized and based on the patient's specific needs and response to treatment, as recommended by recent guidelines 1.

From the Research

Treatment of Ascites

  • The treatment of ascites typically involves a combination of dietary changes and diuretic therapy 2, 3.
  • A low-sodium diet is essential in the treatment of ascites, with patients advised to limit their sodium intake to 2 grams per day 2.
  • Diuretics, such as spironolactone and furosemide, are used to enhance sodium excretion and promote diuresis 2, 4, 5, 6, 3.

Diuretic Therapy

  • Spironolactone is often used as the initial diuretic, with furosemide added if necessary 2, 4, 6, 3.
  • The recommended initial dose of spironolactone is 100-200 mg/d, with a maximum dose of 400 mg/d 2.
  • Furosemide is typically started at a dose of 20-40 mg/d, with a maximum dose of 160 mg/d 2.
  • Studies have shown that spironolactone alone can be as effective as combination therapy with furosemide in the treatment of moderate ascites 4.

Complications of Ascites

  • Refractory ascites is a complication of ascites that is unresponsive to diuretic therapy, and has a poor prognosis 2.
  • Other complications of ascites include hepatorenal syndrome and spontaneous bacterial peritonitis 5, 3.
  • Treatment options for refractory ascites include serial therapeutic paracentesis, transjugular intrahepatic stent-shunt (TIPS), and liver transplantation 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.